REBETOL®
(ribavirin)
CRIXIVAN®
(indinavir sulfate)
ISENTRESS®
(raltegravir)
DELSTRIGO
(doravirine,
lamivudine, and
tenofovir disoproxil
fumarate)
PIFELTRO
(doravirine)
GARDASIL®
[Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine]
GARDASIL®9
[human papillomavirus 9-valent vaccine, recombinant]
JANUVIA®
(sitagliptin phosphate)
JANUMET®
(sitagliptin/metformin HCl)
VARICELLA ZOSTER VIRUS-CONTAINING VACCINES


 

Merck & Co., Inc. is one of a number of pharmaceutical companies who participate in the Antiretroviral Pregnancy Registry, which is coordinated by Syneos Health. Since patients with HIV/AIDS are often placed on multiple-drug therapy, this cooperative registry collects, analyzes, and reports information on individual as well as combination drug regimens. To obtain an annual report from the Antiretroviral Pregnancy Registry or to obtain the forms to enroll a patient, click on the link below or call 1-800-258-4263

The Antiretroviral Pregnancy Registry

 

 

DELSTRIGO® (doravirine/lamivudine/tenofovir disoproxil fumarate) | Official Site
PIFELTRO® (doravirine) | Official Site
ISENTRESS® (raltegravir) and ISENTRESS® HD (raltegravir) | Official Site


CRIXIVAN  |  GARDASIL  |  GARDASIL 9  |  ISENTRESS  |  JANUVIA  |  JANUMET  |  PROQUAD  |  REBETOL  |  VARIVAX  |  ZOSTAVAX  | 
Home  |  Privacy  |  Terms of use  |  Accessiblity

Copyright © 2025 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.